Fenofibrate ameliorates ocular surface inflammation in diabetic keratopathy
This first clinical trial demonstrated that oral fenofibrate ameliorates diabetic ocular surface inflammation, providing a novel therapeutic option for diabetic keratopathy.
Authors
- Isabelle Xin Yu Lee
- Thomas Chuen Lam (ORCID: https://orcid.org/0000-0002-3511-5620)
- Charmaine Toh (ORCID: https://orcid.org/0000-0002-5669-8685)
- Daqian Lu (ORCID: https://orcid.org/0000-0003-2804-2424)
- Victoria Hsu
- Hong Chang Tan
- Hassan Mansoor (ORCID: https://orcid.org/0000-0002-7198-0582)
- Chang Liu (ORCID: https://orcid.org/0000-0003-4641-5108)
- Lei Zhou (ORCID: https://orcid.org/0000-0001-5893-6002)
- Mingyi Yu (ORCID: https://orcid.org/0009-0004-1486-259X)
- Fengyi Liu (ORCID: https://orcid.org/0009-0007-0597-5498)
- Yu‐Chi Liu (ORCID: https://orcid.org/0000-0001-5408-0382)
Institutions
- Hong Kong Polytechnic University (HK)
- Nanyang Technological University (SG)
- Singapore General Hospital (SG)
- University of Cambridge (GB)
- Singapore National Eye Center (SG)
- Singapore Eye Research Institute (SG)
Publication Details
- Journal
- The Ocular Surface
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.jtos.2025.05.010
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- National Medical Research Council